COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Acceptability and Feasibility of Unsupervised HIV Self-Testing Among Networks of Men (STEP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03891407
Recruitment Status : Recruiting
First Posted : March 27, 2019
Last Update Posted : July 11, 2019
Information provided by (Responsible Party):
Donaldson Conserve, PhD, University of South Carolina

Brief Summary:
The purpose of this study is to recruit and train men to promote HIV self-testing to their network members in their camps and examine the efficacy of a peer-led HIV self-testing intervention on the uptake of HIV testing among men.

Condition or disease Intervention/treatment Phase
HIV Infections HIV/AIDS Hiv Diagnostic Test: Self-Testing Education and Promotion Not Applicable

Detailed Description:
The research is the first evaluation of an unsupervised HIV self-testing strategy in Tanzania focusing on networks of heterosexual men. The reasons for focusing on heterosexual men is because heterosexual contact is the primary mode of HIV transmission in Tanzania and data from our previous trial indicate that 97% of the male camp members are heterosexual. Moreover it will be the first intervention to engage male peer leaders to promote HIV self-testing in their social networks in Tanzania. We will build on previous work our research team has conducted to identify 'camps' or local venues where young men socialize with elected leaders and members pay membership dues. Our previous intervention has proven successful to recruit and train leaders from camps to serve as community health leaders in their respective camps, with the goal of changing social norms related to HIV and gender-based violence. A novel approach to the proposed research is that we will leverage the work we have conducted within camps with social networks of men to test the acceptability and feasibility of oral fluid-based HIV self-testing and confirmatory blood-based HIV testing within existing networks of men that we know we can access through stable social venues. We will recruit male camp leaders to train them about HIV self-testing and instruct them to return to their camps and engage their male peers by informing them about HIV self-testing for prior to our research team offering participants the opportunity to self-test.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 500 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Participants who agree to self-test will receive pretest counseling and a 10 minute demonstration, including a video in addition to verbal instructions, of how to use an oral self-test kit from a trained HIV counselor. After counseling, participants will receive 2 oral fluid self-test kits to conduct the self-test at home or in a private location during the next 3 months, a phone number to call in case they need assistance when performing the self-test at home, and a location where to return the used self-test kits and collect more test kits throughout the study period. Upon returning the used self-test kits after every 3 months, participants will be able to share their self-test result with the counselor. Participants will also be asked at each pick-up time to demonstrate they can use the kit to ensure participants continue to receive correct self-test results throughout the study period.
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Acceptability and Feasibility of Unsupervised HIV Self-Testing Among Networks of Men:Tanzania STEP (Self-Testing Education and Promotion) Project
Actual Study Start Date : June 1, 2019
Estimated Primary Completion Date : January 1, 2020
Estimated Study Completion Date : June 1, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS

Arm Intervention/treatment
Experimental: HIV Self-testing Group
Camp members will receive information about HIV self-testing from peer educators who will be nominated by you and other camp members in your camp. Camp members in the STEP project will receive pretest counseling and a 10 minute demonstration. They will receive 1 oral fluid HIV self-test kit to conduct the self-test at home or in a private location during the next 1 month and a phone number to call in case you need assistance when performing the self-test at home. They will also receive information about the nearest HIV Care and Treatment Center where they can seek a confirmatory HIV test and start HIV treatment in the event of a positive self-test result.
Diagnostic Test: Self-Testing Education and Promotion
Camp members will receive the Self-Testing Education and Promotion (STEP locally referred to as Mate Yako Afya Yako) intervention and will receive HIV-counseling and oral HIV self-testing kits.

No Intervention: Non-intervention Group
Camp members will be encouraged to seek HIV testing at the clinics.

Primary Outcome Measures :
  1. Number of HIV self-testing kits distributed in the past 3 Months [ Time Frame: 3 months ]
    Camp members' use of the HIV self-testing kits will be evaluated at 3 months

Secondary Outcome Measures :
  1. Number of camp members who self-report HIV self-testing in the past 3 months [ Time Frame: 3 months ]
    Camp members will self-report HIV self-testing at 3 Months

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Male members of participating camps.
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Participant is at least 18 years old
  • Has been member of the camp for at least 3 months
  • Visits camp at least once a week
  • Intends to live in Dar es Salaam for next 6 months
  • Has not had suicidal thoughts in the past
  • Willing to give contact information of self and relative or friend

Exclusion Criteria:

  • Does not meet all inclusion criteria
  • Unable to participate due to psychological disturbance, cognitive impairment or threatening behavior

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03891407

Layout table for location contacts
Contact: Donaldson Conserve, PhD 9174436124

Layout table for location information
Tandale Community Recruiting
Dar Es Salaam, Tanzania
Contact: Gaspar Mbita         
Sponsors and Collaborators
University of South Carolina
Layout table for additonal information
Responsible Party: Donaldson Conserve, PhD, Study Coordinator for Donaldson Conserve, University of South Carolina Identifier: NCT03891407    
Other Study ID Numbers: Pro00072005
First Posted: March 27, 2019    Key Record Dates
Last Update Posted: July 11, 2019
Last Verified: July 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: Yes
Additional relevant MeSH terms:
Layout table for MeSH terms
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases